T K Marras
Overview
Explore the profile of T K Marras including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
233
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Minuk L, Brode S, Mehrabi M, Sharma M, Stobart M, Soualhine H, et al.
Antimicrob Agents Chemother
. 2024 May;
68(6):e0008424.
PMID: 38758004
When using amikacin to treat complex pulmonary disease (MAC-PD), a minimum inhibitory concentration resistance breakpoint of ≥64 mcg/mL is recommended. We explored whether amikacin resistance characterized by phenotypic drug susceptibility...
2.
Brode S, Daley C, Marras T
Int J Tuberc Lung Dis
. 2014 Oct;
18(11):1370-7.
PMID: 25299873
Setting: Tuberculosis (TB) rates are decreasing in many areas, while non-tuberculous mycobacteria (NTM) infection rates are increasing. The relationship between the epidemiology of TB and NTM infections is not well...
3.
Damaraju D, Jamieson F, Chedore P, Marras T
Int J Tuberc Lung Dis
. 2013 Apr;
17(5):676-81.
PMID: 23575335
Setting And Objective: There are limited data regarding the frequency and significance of co-isolating pulmonary non-tuberculous mycobacteria (NTM) in patients with pulmonary tuberculosis (PTB). Design: We identified all patients with...
4.
Leber A, Marras T
Eur Respir J
. 2010 Sep;
37(5):1158-65.
PMID: 20817704
Treatment of pulmonary nontuberculous mycobacterial (NTM) infection is complex, requiring multiple antibiotics and a prolonged treatment course. We determined the monthly cost of treating patients with pulmonary NTM infections in...
5.
Leber A, Carette S, Chapman K, Hwang D, Singer L, Marras T
Can Respir J
. 2010 Jul;
17(3):e42-4.
PMID: 20617213
Primary or nonobstructive, endogenous lipoid pneumonia is a rare clinical entity usually associated with an underlying systemic disease. The present report describes a case involving a 21-year-old man with systemic-onset...
6.
Varadi R, Marras T
Int J Tuberc Lung Dis
. 2009 Oct;
13(10):1210-8.
PMID: 19793424
Setting: The incidence of Mycobacterium xenopi infections is increasing worldwide. The characteristics and optimal management of patients with pulmonary M. xenopi infections have not been well established. Methods: Systematic review...
7.
Maimon N, Lipton J, Chan C, Marras T
Bone Marrow Transplant
. 2009 May;
44(2):69-73.
PMID: 19430505
Bronchiolitis obliterans (BO) is a serious complication of hematopoietic SCT (HSCT). The condition is believed to be the result of an inflammatory part of the GVHD. Although many BO patients...
8.
Maimon N, Nopmaneejumruslers C, Marras T
Eur Respir J
. 2008 Jan;
31(5):1068-76.
PMID: 18216053
The aim of the present study was to systematically compare outcomes between antibiotic classes in treating outpatient community-acquired pneumonia, with regard to antibacterials active against atypical organisms, as well as...
9.
Marras T, Chan C, Lipton J, Messner H, Szalai J, Laupacis A
Bone Marrow Transplant
. 2004 Jan;
33(5):509-17.
PMID: 14716347
We studied long-term pulmonary function testing (PFT) in a retrospective cohort of 6-month survivors of allogeneic marrow transplant (BMT) between 1980 and 1997. Of 593 patients, 73, 71 and 65%...
10.